Proteolytic fragments of insulin-like growth factor binding protein-3: N-terminal sequences and relationships between structure and biological activity

Comptes Rendus de l'Academie des Sciences - Serie III

Volumn 320, Issue 8, 1997, Pages 621-628

  Lalou, Claude ^a   Sawamura, Steven ^b   Segovia, Berta ^a   Ogawa, Yasushi ^b   Binoux, Michel ^a  

^a HÔPITAL SAINT ANTOINE   (France)

^b Celtrix Pharmaceuticals   (United States)

Author keywords

Cell growth; IGFBPs; IGFs; N terminal sequences; Proteolytic fragments

Indexed keywords

SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; BINDING AFFINITY; CELL GROWTH; CELL KINETICS; CELL LINE; CONTROLLED STUDY; GROWTH INHIBITION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MITOSIS INHIBITION; NONHUMAN; OSTEOBLAST; PROTEIN DEGRADATION; PROTEIN ISOLATION; STRUCTURE ACTIVITY RELATION;

ANIMALIA;

EID: 0030664288     PISSN: 07644469     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0764-4469(97)85695-8     Document Type: Article

References (24)

1. Humbel R.E. 1990. Insulin-like growth factors I and II. Eur. J. Biochem. 190, 445-462
2. Jones J.I. Clemmons D.R. 1995. Insulin-like growth factors and their binding proteins: Biological actions. Endocrine Rev. 16, 3-34
3. Rechler M.M. 1993. Insulin-like growth factor binding proteins. In: Vitamins and Hormones (D.B. McCormick, ed.), Academic Press, San Diego, USA, 1-114
4. Shimasaki S., Ling N. 1991. Identification and molecular characterization of insulin-like growth factor binding proteins (IGFBP-1, -2, -3, -4, -5 and -6). Prog. Growth Factor Res. 3, 243-266
5. Hardouin S., Hossenlopp P., Segovia B., Seurin D., Portolan G., Lassarre C., Binoux M. 1987. Heterogeneity of insulin-like growth factor binding proteins and relationships between structure and affinity. I. Circulating forms in man. Eur. J. Biochem. 170, 121-132
6. Baxter R.C., Martin J.L. 1989. Structure of the Mr 140 000 growth hormone-dependent insulin-like growth factor binding protein complex: determination by reconstitution and affinity labeling. Proc. Natl. Acad. Sci. USA. 86, 6898-6902
7. Binoux M., Hossenlopp P. 1988. Insulin-like growth factor (IGF) and IGF-binding proteins: comparison of human serum and lymph. J. Clin. Endocrinol. Metab. 67, 509-514
8. Guler H.P., Zapf J., Schmid C., Froesch E.R. 1989. Insulin-like growth factors I and II in healthy man. Estimations of half-lives and production rates. Acta Endocrinol. (Copenh) 121, 753-758
9. Baxter R.C. 1993. Circulating binding proteins for the insulin-like growth factors. Trends Endocrinol. Metab. 4, 91-96
10. Hossenlopp P., Segovia B., Lassarre C., Roghani M., Bredon M., Binoux M. 1990. Evidence of enzymatic degradation of insulin-like growth factor binding proteins in the '150 K' complex during pregnancy. J. Clin. Endocrinol. Metab. 71, 797-805
11. Giudice L.C., Farrell E.M., Pham H., Lamson G., Rosenfeld R.G. 1990. Insulin-like growth factor binding proteins in maternal serum throughout gestation and in the puerperium: effects of a pregnancy-associated serum protease activity. J. Clin. Endocrinol. Metab. 71, 806-816
12. Lassarre C., Binoux M. 1994. Insulin-like growth factor binding protein-3 is functionally altered in pregnancy plasma. Endocrinology 134, 1254-1262
13. Blat C., Villaudy J., Binoux M. 1994. In vivo proteolysis of serum insulin-like growth factor (IGF) binding protein-3 results in increased availability of IGF to target cells. J. Clin. Invest. 93, 2286-2290
14. Lalou C., Silve C., Rosato R., Segovia B., Binoux M. 1994. Interactions between insulin-like growth factor-I (IGF-I) and the system of plasminogen activators and their inhibitors in the control of IGF binding protein-3 production and proteolysis in human osteosarcoma cells. Endocrinology 135, 2318-2326
15. Angelloz-Nicoud P., Binoux M. 1995. Autocrine regulation of cell proliferation by the IGF and IGF binding protein-3 protease system in a human prostate carcinoma cell line (PC-3). Endocrinology 136, 5485-5492
16. Blat C., Delbé J., Villaudy J., Chatelain G., Goldé A., Harel L. 1989. Inhibitory diffusible factor 45 bifunctional activity: as a cell growth inhibitor and as an IGF binding protein. J. Biol. Chem. 264, 12449-12454
17. Cohen P., Lamson G., Okajima T., Rosenfeld R.G. 1993. Transfection of the human insulin-like growth factor binding protein-3 gene into balb/c fibroblasts inhibits cellular growth. Mol. Endocrinol. 7, 380-386
18. Oh Y., Müller H.L., Lamson G., Rosenfeld R.G. 1993. Insulin-like growth factor (IGF)-independent action of IGF-binding protein-3 on Hs578T human breast cancer cells. J. Biol. Chem. 268, 14964-14971
19. Lalou C., Lassarre C., Binoux M. 1996. A proteolytic fragment of insulin-like growth factor (IGF) binding protein-3 that fails to bind IGFs inhibits the mitogenic effects of IGF-I and insulin. Endocrinology 137, 3206-3212
20. Hossenlopp P., Binoux M. 1994. Use of peptide ligands for the detection of binding proteins by Western ligand blotting. In: Protein Blotting, a Practical Approach, Oxford University Press, 169-186
21. Zapf J., Kiefer M., Merryweather J., Masiarz F., Bauer D., Born W., Fischer J.A., Froesch E.R. 1990. Isolation from adult human serum of four insulin-like growth factor (IGF) binding proteins and molecular cloning of one of them that is increased by IGF-I administration and in extrapancreatic tumor hypoglycemia. J. Biol. Chem. 265, 14892-14898
22. Roghani M., Segovia B., Whitechurch O., Binoux M. 1991. Purification from human cerebrospinal fluid of insulin-like growth factor binding proteins (IGFBPs). 2. Isolation of IGFBP-2, an altered form of IGFBP-3 and a new IGFBP species. Growth Regulation 1, 125-130
23. Angelloz-Nicoud P., Harel L, Binoux. 1996. Recombinant human Insulin-like growth factor (IGF) binding protein-3 stimulates prostate carcinoma cell proliferation via an IGF-dependent mechanism. Role of serine proteases. Growth Regulation 6, 130-136
24. Firth S.M., Baxter R.C. 1995. The role of glycosylation in the action of IGFBP-3. Prog. in Growth Factor Res. 6, 223-229